880 related articles for article (PubMed ID: 11237737)
1. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
Frändberg PA; Doufexis M; Kapas S; Chhajlani V
Biochem Biophys Res Commun; 2001 Mar; 281(4):851-7. PubMed ID: 11237737
[TBL] [Abstract][Full Text] [Related]
2. Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4R.
Haskell-Luevano C; Hendrata S; North C; Sawyer TK; Hadley ME; Hruby VJ; Dickinson C; Gantz I
J Med Chem; 1997 Jul; 40(14):2133-9. PubMed ID: 9216831
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanism of the intracellular segments of the melanocortin-4 receptor for NDP-MSH signaling.
Yang Y; Chen M; Loux TJ; Georgeson KE; Harmon CM
Biochemistry; 2005 May; 44(18):6971-9. PubMed ID: 15865442
[TBL] [Abstract][Full Text] [Related]
4. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.
Haskell-Luevano C; Nikiforovich G; Sharma SD; Yang YK; Dickinson C; Hruby VJ; Gantz I
J Med Chem; 1997 May; 40(11):1738-48. PubMed ID: 9171884
[TBL] [Abstract][Full Text] [Related]
5. Substituted NDP-MSH peptides paired with mutant melanocortin-4 receptors demonstrate the role of transmembrane 6 in receptor activation.
Fleck BA; Ling N; Chen C
Biochemistry; 2007 Sep; 46(37):10473-83. PubMed ID: 17713970
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional molecular models of the hMC1R melanocortin receptor: complexes with melanotropin peptide agonists.
Haskell-Luevano C; Sawyer TK; Trumpp-Kallmeyer S; Bikker JA; Humblet C; Gantz I; Hruby VJ
Drug Des Discov; 1996 Dec; 14(3):197-211. PubMed ID: 9017363
[TBL] [Abstract][Full Text] [Related]
7. Identification of ligand binding residues in extracellular loops of the melanocortin 1 receptor.
Chhajlani V; Xu X; Blauw J; Sudarshi S
Biochem Biophys Res Commun; 1996 Feb; 219(2):521-5. PubMed ID: 8605020
[TBL] [Abstract][Full Text] [Related]
8. Co-operative regulation of ligand binding to melanocortin receptor subtypes: evidence for interacting binding sites.
Kopanchuk S; Veiksina S; Petrovska R; Mutule I; Szardenings M; Rinken A; Wikberg JE
Eur J Pharmacol; 2005 Apr; 512(2-3):85-95. PubMed ID: 15840392
[TBL] [Abstract][Full Text] [Related]
9. Potent and selective agonists of alpha-melanotropin (alphaMSH) action at human melanocortin receptor 5; linear analogs of alpha-melanotropin.
Bednarek MA; MacNeil T; Tang R; Fong TM; Cabello MA; Maroto M; Teran A
Peptides; 2007 May; 28(5):1020-8. PubMed ID: 17376561
[TBL] [Abstract][Full Text] [Related]
10. [Detection of binding activity and biologic effect of a novel alpha-melanocyte-stimulating hormone analogue].
Ying Y; Lan XP; Tian YP
Yao Xue Xue Bao; 2007 Mar; 42(3):269-73. PubMed ID: 17520825
[TBL] [Abstract][Full Text] [Related]
11. Glutamine235 and arginine272 in human melanocortin 5 receptor determines its low affinity to MSH.
Frändberg PA; Xu X; Chhajlani V
Biochem Biophys Res Commun; 1997 Jul; 236(2):489-92. PubMed ID: 9240466
[TBL] [Abstract][Full Text] [Related]
12. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
[TBL] [Abstract][Full Text] [Related]
13. Molecular determination of agouti-related protein binding to human melanocortin-4 receptor.
Yang Y; Chen M; Lai Y; Gantz I; Yagmurlu A; Georgeson KE; Harmon CM
Mol Pharmacol; 2003 Jul; 64(1):94-103. PubMed ID: 12815165
[TBL] [Abstract][Full Text] [Related]
14. Analogs of alpha-melanocyte stimulating hormone with high agonist potency and selectivity at human melanocortin receptor 1b: the role of Trp(9) in molecular recognition.
Bednarek MA; Macneil T; Tang R; Fong TM; Angeles Cabello M; Maroto M; Teran A
Biopolymers; 2008 May; 89(5):401-8. PubMed ID: 17926329
[TBL] [Abstract][Full Text] [Related]
15. Site-directed mutagenesis of alpha 2A-adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonists.
Wang CD; Buck MA; Fraser CM
Mol Pharmacol; 1991 Aug; 40(2):168-79. PubMed ID: 1678850
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis for the interaction of [Nle4,D-Phe7]melanocyte stimulating hormone with the human melanocortin-1 receptor.
Yang Yk; Dickinson C; Haskell-Luevano C; Gantz I
J Biol Chem; 1997 Sep; 272(37):23000-10. PubMed ID: 9287296
[TBL] [Abstract][Full Text] [Related]
17. De novo design, synthesis, and pharmacology of alpha-melanocyte stimulating hormone analogues derived from somatostatin by a hybrid approach.
Han G; Haskell-Luevano C; Kendall L; Bonner G; Hadley ME; Cone RD; Hruby VJ
J Med Chem; 2004 Mar; 47(6):1514-26. PubMed ID: 14998337
[TBL] [Abstract][Full Text] [Related]
18. Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants.
Haskell-Luevano C; Cone RD; Monck EK; Wan YP
Biochemistry; 2001 May; 40(20):6164-79. PubMed ID: 11352754
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationships of novel cyclic alpha-MSH/beta-MSH hybrid analogues that lead to potent and selective ligands for the human MC3R and human MC5R.
Balse-Srinivasan P; Grieco P; Cai M; Trivedi D; Hruby VJ
J Med Chem; 2003 Aug; 46(17):3728-33. PubMed ID: 12904077
[TBL] [Abstract][Full Text] [Related]
20. Functional significance of the BBXXB motif reversed present in the cytoplasmic domains of the human follicle-stimulating hormone receptor.
Timossi C; Ortiz-Elizondo C; Pineda DB; Dias JA; Conn PM; Ulloa-Aguirre A
Mol Cell Endocrinol; 2004 Aug; 223(1-2):17-26. PubMed ID: 15279907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]